Nexa News

A groundbreaking gene therapy, GeneX-25, has shown promising results in Phase II clinical trials, offering hope for the treatment of rare genetic disorders. The therapy utilizes CRISPR-Cas9 technology and could revolutionize personalized medicine.

Scientists have made significant advances in gene editing, particularly with CRISPR-Cas9, which could revolutionize the treatment of genetic diseases and pave the way for personalized medicine.